Assets
BN
Brookfield Asset Management has successfully closed its first Brookfield Infrastructure Structured Solutions Fund, reaching its $1 billion fundraising target.
Portfolio Pulse from
March 11, 2025 | 11:15 am
ELRRF
Eloro Resources Ltd. has announced significant assay results from its diamond drilling program at the Iska Iska silver-tin polymetallic project in Bolivia, revealing a major silver zone with high-grade intersections.
Portfolio Pulse from
March 11, 2025 | 11:15 am
DOW
Dow Inc. announced early results of its cash tender offer to purchase certain debt securities of its subsidiaries, including Rohm and Haas and Union Carbide Corporation.
Portfolio Pulse from
March 11, 2025 | 11:15 am
NDOI
Endo, Inc. has announced the divestiture of its International Pharmaceuticals business to Knight Therapeutics Inc. for up to $99 million. The deal includes an upfront payment of $84 million and potential future payments of $15 million.
Portfolio Pulse from
March 11, 2025 | 11:00 am
CLMT
Calumet Specialty Products Partners reported in-line Q4 2024 results, with asset sales and cash generation efforts creating a favorable buying opportunity. Specialty EBITDA is expected to improve in 2025 due to stronger Gulf Coast spreads and operational efficiencies.
Portfolio Pulse from
March 11, 2025 | 9:30 am
VGZ
Vista Gold Corp.'s Mt Todd project in Australia is economically viable with a revised plan for 15,000 tonnes/day production and $400M capital requirements. The feasibility study shows a payback period of 8 months at current gold prices. VGZ is debt-free with $17M in cash but needs a partner to start mining.
Portfolio Pulse from
March 11, 2025 | 9:00 am
TGOPF
3i Group's significant stake in the European value-retail chain Action is valued at approximately £31 billion. Action's strong financial performance and growth in Europe suggest it can meet high market expectations.
Portfolio Pulse from
March 11, 2025 | 9:00 am
KFFLF
KEFI Gold and Copper PLC announced that its Tulu Kapi project in Ethiopia is on track, with a key financing milestone expected soon. Credit committee approval has been granted by its lending banks, with procedural steps to be completed by March 31.
Portfolio Pulse from
March 11, 2025 | 8:45 am
SYGGF
Synairgen PLC plans to delist from London's AIM market and go private after failing to secure necessary investment. The biotech firm has been developing an inhaled treatment for respiratory infections.
Portfolio Pulse from
March 11, 2025 | 8:15 am
Previous
Next